Abstract
In certain etiological groups of patients with fulminant hepatic failure, poor survival may be due to lack of liver regeneration.In vitro experiments have shown that fulminant hepatic failure serum is cytotoxic to rabbit hepatocytes and inhibits DNA synthesis on short-term incubation with isolated regenerating rat hepatocytes. When fulminant hepatic failure serum is injected into partially hepatectomized rats at the time of maximal DNA synthesis, [3H]thymidine incorporation into hepatic DNA is reduced significantly. The effect is greater with sera obtained from patients with fulminant hepatic failure due to non-A, non-B hepatitis or an adverse drug reaction and is associated with a<10,000-dalton fraction. No stimulation of DNA synthesis is observed with injection of the >10,000-dalton serum fraction into normal rats. In preliminary experiments, no increase in epidermal growth factor production has been found in liver failure. Overall, the substances present in fulminant hepatic failure serum appear to be inhibitory rather than stimulatory for liver cell regeneration.
References
Gazzard BG, Portmann B, Murray-Lyon IM, Williams R: Causes of death in fulminant hepatic failure and relationship to quantitative assessment of parenchymal damage. Q J Med 44:615–626, 1975
Rakela J, Lange SM, Ludwig, J, Baldus WP: Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 60:289–292, 1985
Milandri M, Gaub J, Ranek L: Evidence for liver cell proliferation during fatal acute liver failure. Gut 21:423–427, 1980
Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S, Daikuhara Y: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 166:139–150, 1986
Hughes RD, Cochrane AMG, Thomson AD, Murray-Lyon IM, Williams R: The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 57:348–353, 1976
Haas T, Holloway CJ, Osterthun V, Trautschold I: Hepatotoxic effects of sera from patients with fulminant hepatitis B on isolated rat hepatocytes in culture. J Clin Chem Clin Biochem 19:283–286, 1981
Gove CD, Hughes RD, Williams R: Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat livers by serum from patients with fulminant hepatic failure. Br J Exp Pathol 63:547–553, 1982
Yamada H, Hughes RD, Gove CD, Williams R: Effects of fulminant hepatic failure serum on hepatic DNA synthesis in normal and partially hepatectomized rats. Eur J Gastroenterol Hepatol 2:483–488, 1990
Morley CGD, Kingdon HS: Use of3H thymidine for measurement of DNA synthesis in rat liver—a warning. Anal Biochem 45:298–305, 1972
Thaler FJ, Michaelopoulos GK: Hepatopoietin A: Partial characterisation and trypsin activation of a hepatocyte growth factor. Cancer Res 45:2545–2549, 1985
Selden C, Johnstone R, Darby H, Gupta S, Hodgson HJF: Human serum does contain a high molecular weight hepatocyte growth factor: Studies pre-and post-hepatic resection. Biochem Biophys Res Commun 139:361–366, 1986
Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81:414–419, 1988
Hughes RD, Gregory H, Willshire IR, Moore KP, Williams R: Urinary excretion of epidermal growth factor in acute liver failure: Preliminary results. Med Sci Res 18:515–516, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hughes, R.D., Yamada, H., Gove, C.D. et al. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure. Digest Dis Sci 36, 816–819 (1991). https://doi.org/10.1007/BF01311242
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01311242